Insights from the 2024 WHO Global Tuberculosis Report – More Comprehensive Action, Innovation, and Investments required for achieving WHO End TB goals

• Delia Goletti,
• Graeme Meintjes,
• Bruno B. Andrade,
• Alimuddin Zumla,
• Shui Shan Lee

Affiliations

Delia Goletti

Translational Research Unit, National Institute for Infectious Diseases “Lazzaro Spallanzani”- Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy; Corresponding author.

Graeme Meintjes

Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom; Department of Medicine and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa

Bruno B. Andrade

Laboratory of Clinical and Translational Research, Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Brazil; The BRIGHT lab, Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Institute, Salvador, Brazil

Alimuddin Zumla

Center for Clinical Microbiology, Division of Infection and Immunity, University College London, and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, United Kingdom

Shui Shan Lee

International Society for Infectious Diseases; S.H Ho Research Centre for Infectious Diseases, The Chinese University of Hong Kong, Hong Kong, China